Data Conversion Laboratory Supports Newest SPL Requirements For Life Sciences Industry
FRESH MEADOWS, N.Y., Aug. 4 /PRNewswire/ -- Data Conversion Laboratory, Inc. (DCL) , providing conversion services and software to publishers, information aggregators, industry, government, libraries and documentation developers, continues to be in the forefront supporting the life scien...Human Genome Sciences Announces Second-Quarter 2009 Financial Results and Key Developments
ROCKVILLE, Md., July 22 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) today announced financial results for the quarter ended June 30, 2009, and provided highlights of recent key developments. (Logo: http://www.newscom.com/cgi-bin/prn...Life Sciences & Health Care Companies Unprepared for Information Security Risks: Deloitte Survey
NEW YORK, July 22 /PRNewswire/ -- Bolstered by the promise of the information age, coupled with billions of dollars in economic stimulus funding, life sciences and health care companies still may not meet lofty expectations of maximizing the value of data and automation efficiencies...Derma Sciences Announces First Commercial Sales of BIOGUARD(TM) Barrier Dressings
PRINCETON, N.J., June 23 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that it has begun shipping BIOGUARD(TM) Barrier Dressings to customers. Separately, the company announced that it has been awarded re...SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
MUMBAI, India, Aug. 5 /PRNewswire/ -- SIRO Clinpharm, a global, full service Contract Research Organization (CRO) founded in India, today announced the successful completion of the implementation phase of the Oracle Life Science Application Suite (OLSAS) by going live with Oracle S...Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
BELLEVILLE, Ontario and CHADDS FORD, Pa., July 10 /PRNewswire-FirstCall/ -- Bioniche Life Sciences Inc. (TSX: BNC) and Endo Pharmaceuticals (Nasdaq: ENDP ) jointly announced today that Endo has licensed from Bioniche the exclusive rights to develop and market Urocidin(TM) in the U.S. with ...Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
- First-in-class treatment for inhalation anthrax - ROCKVILLE, Md., May 21 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its human monoclona...PediaVision S04 Vision Screener
Description:... PediaVision LLC is a life sciences company dedicated to solving the critical problem of undiagnosed vision problems affecting children worldwide....CST-2000 Flexible Cystoscope System
Description:...le minimizing the costs of reprocessing and cleaning procedures, maintenance, and service that are associated with conventional endoscopes. The Vision sciences CST-2000 Flexible Cystoscope System offers ease-of-use, rapid turnaround between procedures, and reduced costs associated with maintenance and service...I-Plant™ 125 Brachytherapy Seeds
Description:...seed cores in large quantities, compared to the radioactive wet chemistry method of manufacturing existing Iodine-125 and Palladium-103 seeds. Implant sciences sends the seed cores to a nuclear reactor for activation followed by final assembly, testing, and assaying....New species of phallus-shaped mushroom named after California Academy of Sciences scientist
SAN FRANCISCO (June 15, 2009) - It's two inches long, grows on wood, and is shaped like a phallus. A new species of stinkhorn mushroom, Phallus drewesii , has been discovered on the African island of Sao Tome and graces the upcoming cover of the journal Mycologia . The mushroom is named after R...Swine flu experts gather at New York Academy of Sciences May 28
The very latest information on the 2009 swine influenza (H1N1) outbreak is the subject of a landmark afternoon symposium hosted by the New York Academy of Sciences on Thursday, May 28. Speakers will discuss the new recombinant virus, epidemiology, treatment, vaccine development and the public heal...Springer and Senckenberg society to collaborate on life sciences and geosciences journals
Springer and the Senckenberg Gesellschaft fuer Naturforschung will collaborate on the publication of two scientific journals starting in March 2009. Palaeobiodiversity and Palaeoenvironments and Marine Biodiversity , both quarterly journals, will receive maximum exposure through Springer's abs...Biophysical sciences program receives $2 million training grant
The University of Chicago has developed a recipe for creating first-rate interdisciplinary biophysical scientists. Two of the key ingredients: take the very best physical sciences undergraduates, then put them through an experimental biology wringer during their first year as graduate students...The Earth Observatory of Singapore devoted to the study of earth sciences officially opens
The Earth Observatory of Singapore (EOS) which aspires to be a leading world institution for understanding and addressing several of civilisation's most serious environmental threats including earthquakes, tsunamis, volcanic eruptions and climate change aims to provide invaluable research and da...NTU seals global partnerships on environmental sciences R&D
Bacteria is often thought of as harmful yet few know that bacteria can be used for water treatment. To further research the role of bacteria in water treatment, Nanyang Technological University (NTU) is partnering with three leading institutions across three continents. Researchers will study the ...Advanced Life Sciences to Host 2009 Second Quarter Financial Results Conference Call and Webcast
CHICAGO, Aug. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), announced today that it will host a conference call and webcast discussing the Company's 2009 second quarter results on Tuesday, August 11, 2009 at 10:00 a.m. (EDT). Michael T. Fla...SK Life Sciences has Licensed Pristima
Xybion Medical Systems, is pleased to announce that SK Life Science, Inc. (SKLSI), has licensed Pristima for its Research and Development facility in Fair Lawn, New Jersey. Cedar Knolls, NJ (PRWEB) August 3, 2009 -- Xybion Medical Systems, a world leader in toxicology a...Human Genome Sciences Announces Closing of Public Offering
ROCKVILLE, Md., Aug. 3 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) today announced the closing of its public offering of 26,697,250 newly issued shares of its common stock at a price to the public of $14.00 per share, which includes 3,482,250 shares sold upon exerc...Caliper Life Sciences Reports Second Quarter 2009 Results
HOPKINTON, Mass., July 30 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ) today reported that for the second quarter of 2009 revenues were $32.1 million compared to $34.0 million for the second quarter of 2008. Divestitures and foreign currency translation negati...Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
BRANFORD, Conn., July 29 /PRNewswire/ -- Marinus Pharmaceuticals, Inc. a developer of drugs to treat serious neurological and psychiatric disorders, today announced the appointment of George F. Horner III of Sofinnova Ventures and Harry T. Rein of Foundation Medical Partners to its Board...Cell biology services from Novascreen-a Caliper Life Sciences Company
Description: NovaScreen offers cell biology, cell culture and molecular biology services for companies who lack a cell culture facility....CNS Side Effect Profile (CNS SEP) from Novascreen-a Caliper Life Sciences Company
Description: Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selecitivty and potential CNS-Side Effect liabilities of compounds....General Side Effect Profile I (GEN SEP I) from Novascreen-a Caliper Life Sciences Company
Description: Compound(s) tested through 63 ligand binding and enzyme assays spanning a broad therapeutic range. This assay panel includes many non human tissue sources and several non-selective assays. Used to determine potential side-effect liabilities of compounds....Cardiovascular/Renal Profile from Novascreen-a Caliper Life Sciences Company
Description: Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds....Gastrointestinal Profile from Novascreen-a Caliper Life Sciences Company
Description: Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential GI liabilities of compounds....Neurological Profile from Novascreen-a Caliper Life Sciences Company
Description: Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential Neurological liabilities of compounds....